Edith Zang

5.0k total citations · 2 hit papers
36 papers, 3.9k citations indexed

About

Edith Zang is a scholar working on Oncology, Epidemiology and Physiology. According to data from OpenAlex, Edith Zang has authored 36 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Edith Zang's work include Smoking Behavior and Cessation (5 papers), Hepatitis B Virus Studies (5 papers) and Immunotherapy and Immune Responses (4 papers). Edith Zang is often cited by papers focused on Smoking Behavior and Cessation (5 papers), Hepatitis B Virus Studies (5 papers) and Immunotherapy and Immune Responses (4 papers). Edith Zang collaborates with scholars based in United States, Sweden and Hungary. Edith Zang's co-authors include Cladd E. Stevens, W. Szmuness, Edward J. Harley, Aaron Kellner, Daniel C. William, William R. Oleszko, John M. Morrison, Richard Sadovsky, Harvey J. Alter and Patricia E. Taylor and has published in prestigious journals such as New England Journal of Medicine, JAMA and Hepatology.

In The Last Decade

Edith Zang

36 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis B Vaccine

1980 821 citations W. Szmuness, Cladd E. Stevens et al. New England Journal of Medicine profile →
Fluorescein Angiography Complication Survey

1986 445 citations Edith Zang et al. profile →

Peers

Countries citing papers authored by Edith Zang

Since Specialization

Citations

This map shows the geographic impact of Edith Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Zang more than expected).

Fields of papers citing papers by Edith Zang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Zang. The network helps show where Edith Zang may publish in the future.

Co-authorship network of co-authors of Edith Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Zang. A scholar is included among the top collaborators of Edith Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Zang. Edith Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular Outcomes After Preeclampsia or Eclampsia Complicated by Myocardial Infarction or Stroke 2012 ·Obstetrics and Gynecology ·Mary Downes Gastrich, (unknown), John Pantazopoulos, Edith Zang, Nora M. Cosgrove, Javier Cabrera, (unknown), Gloria Bachmann, John B. Kostis	11
2	A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously Treated Non–Small-Cell Lung Cancer 2011 ·Clinical Lung Cancer ·Alexander I. Spira, Nicholas Iannotti, Michael A. Savin, Marcus A. Neubauer, Nashat Gabrail, Ronald Yanagihara, Edith Zang, Patricia E. Cole, Dale E. Shuster, Asha Das	26
3	Gender differences relative to smoking behavior and emissions of toxins from mainstream cigarette smoke 2007 ·Nicotine & Tobacco Research ·Assieh A. Melikian, Mirjana V. Djordjevic, (unknown), (unknown), Shuquan Chen, Edith Zang, Joshua Muscat, Steven D. Stellman	62
4	On the occurrence of Leydig cell tumors in the F344 rat 2002 ·Cancer Letters ·John H. Weisburger, Abraham Rivenson, Joel Reinhardt, (unknown), Brian Pittman, Edith Zang	5
5	Tea polyphenols inhibit the formation of mutagens during the cooking of meat 2002 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·John H. Weisburger, Elizabeth Veliath, (unknown), Brian Pittman, Edith Zang, Yukihiko Hara	61
6	Investigation of commercial mitolife as an antioxidant and antimutagen 2001 ·Nutrition ·John H. Weisburger, (unknown), (unknown), Brian Pittman, Edith Zang, Yukihiko Hara, (unknown)	16
7	Reevaluation of the Confounding Effect of Cigarette Smoking on the Relationship between Alcohol Use and Lung Cancer Risk, with Larynx Cancer Used as a Positive Control 2001 ·Preventive Medicine ·Edith Zang, Ernst L. Wynder	22
8	Doses of Nicotine and Lung Carcinogens Delivered to Cigarette Smokers 2000 ·JNCI Journal of the National Cancer Institute ·(unknown), Steven D. Stellman, Edith Zang	220
9	Smoking Trends in the United States between 1969 and 1995 Based on Patients Hospitalized with Non-Smoking-Related Diseases 1998 ·Preventive Medicine ·Edith Zang, Ernst L. Wynder	24
10	Tea polyphenols as inhibitors of mutagenicity of major classes of carcinogens 1996 ·Mutation Research/Genetic Toxicology ·John H. Weisburger, Yukihiko Hara, Lisa Dolan, (unknown), Brian Pittman, Edith Zang	74
11	Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. 1995 ·PubMed ·Chinthalapally V. Rao, Abraham Rivenson, Barbara Simi, Edith Zang, Gary Kelloff, Vernon E. Steele, Bandaru S. Reddy	360
12	The association between body mass index and the relative frequencies of diseases in a sample of hospitalized patients 1994 ·Nutrition and Cancer ·Edith Zang, (unknown)	30
13	Race and Sex Differences in Lung Cancer Risk Associated with Cigarette Smoking 1993 ·International Journal of Epidemiology ·Randall E. Harris, Edith Zang, Judy Anderson, Ernst L. Wynder	196
14	N-ethyl-N-nitrosourea induced brain tumors in rats monitored by nuclear magnetic resonance imaging, plasma proton nuclear magnetic resonance spectroscopy and microscopy 1992 ·Cancer Letters ·(unknown), Michael J. Iatropoulos, Stephen S. Hecht, (unknown), (unknown), Edith Zang, Gary M. Williams	4
15	Cumulative tar exposure. A new index for estimating lung cancer risk among cigarette smokers 1992 ·Cancer ·Edith Zang, E. L. Wynder	68
16	A study of betel quid carcinogenesis—VIII. Carcinogenicity of 3-(methylnitrosamino)propionaldehyde in F344 rats 1992 ·Carcinogenesis ·Akiyoshi Nishikawa, Bogdan Prokopczyk, Abraham Rivenson, Edith Zang, Dietrich Hoffmann	27
17	Voluntary Exercise and Experimental Mammary Cancer 1992 ·Advances in experimental medicine and biology ·Leonard A. Cohen, (unknown), (unknown), Edith Zang	37
18	Oral Contraceptives and Breast Cancer Risk: A Case-Control Study 1990 ·International Journal of Epidemiology ·Randall E. Harris, Edith Zang, Ernst L. Wynder	22
19	Adenosine diphosphate ribosyl transferase responses to a standardized dose of hydrogen peroxide in the mononuclear leukocytes of patients with a diagnosis of cancer 1989 ·Carcinogenesis ·Ronald W. Pero, D.B. Johnson, Daniel G. Miller, Edith Zang, Melvin M. Markowitz, (unknown), (unknown), Leif Salford, Peter P. Sordillo, (unknown), Edward J. Beattie	29
20	Hepatitis B Vaccine in Medical Staff of Hemodialysis Units 1982 ·New England Journal of Medicine ·W. Szmuness, Cladd E. Stevens, Edward J. Harley, Edith Zang, Harvey J. Alter, Patricia E. Taylor, (unknown), (unknown), Aaron Kellner, (unknown)	211

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact